Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:adjuvant |
alum
|
| gptkbp:alsoKnownAs |
FINLAY-FR-2
|
| gptkbp:antigen |
SARS-CoV-2 RBD protein
|
| gptkbp:approvedBy |
2021
|
| gptkbp:boosters |
gptkb:Soberana_Plus
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:countryOfOrigin |
gptkb:Cuba
|
| gptkbp:developedBy |
gptkb:Finlay_Institute
|
| gptkbp:dosesRequired |
2
|
| gptkbp:emergencyServices |
gptkb:Cuba
|
| https://www.w3.org/2000/01/rdf-schema#label |
Soberana 02
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:vaccineType |
vaccine
|
| gptkbp:bfsParent |
gptkb:Soberana
|
| gptkbp:bfsLayer |
7
|